CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

78 hedge funds and large institutions have $168M invested in Cascadian Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
78
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$741K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$30.1M
2 +$18.9M
3 +$16.9M
4
EC
EcoR1 Capital
California
+$12.4M
5
A
Abingworth
United Kingdom
+$3.83M

Top Sellers

1 -$2.22M
2 -$142K
3 -$108K
4
VKH
Virtu KCG Holdings
New York
-$96.1K
5
EWM
Edge Wealth Management
New York
-$85K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$37.5M
2
$36.1M
3
$16.9M
4
$13M
5
$12.4M
6
$7.54M
7
$5.89M
8
$4.61M
9
$3.83M
10
$3.31M
11
$2.78M
12
$2.41M
13
$2.28M
14
$2.25M
15
$2.22M
16
$1.56M
17
$1.42M
18
$1.22M
19
$1.05M
20
$934K
21
$849K
22
$767K
23
$671K
24
$669K
25
$594K